Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
May 15, 2013 -- To date, Amgen, the US biotech drug company, has not had a major presence in China. In February of this year, Amgen said it would use a combination of partnerships and M&A to increase its participation in the China market. The first of these relationships is the Amgen-Zhejiang Beta JV, announced last week, which will promote and distribute Amgen’s colon cancer Vectibix. More details....
Stock Symbol: (NSDQ: AMGN)
Help employers find you! Check out all the jobs and post your resume.